A Study to See the Effect of ICA-105665 in Photosensitive Epilepsy Patients



Status:Archived
Conditions:Neurology, Epilepsy
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:September 2009
End Date:September 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 2, Multi-Center, Single-Blind, Placebo-Controlled Pharmacodynamic Evaluation of ICA-105665 in Epilepsy Patients With a Photo-Induced Paroxysmal Electroencephalographic (EEG) Response


The purpose of this study is to determine the effects of ICA-105665 on the photoparoxysmal
electroencephalography (EEG) response in photosensitive epilepsy patients exposed to
intermittent photic stimulation.


Subjects with epilepsy with a documented photoparoxysmal response to intermittent photic
stimulation will participate. Four subjects will be enrolled at each dose level and will
receive a single dose of placebo and a single dose of ICA-105665 during the study, each
followed by intermittent photic stimulation. The effects of ICA-105665 on the
photoparoxysmal EEG response of each group will be reviewed before the dose is selected for
each subsequent group of subjects.


We found this trial at
3
sites
Clinical Trial Facility
Little Rock, Arkansas
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Clinical Trial Facility
Chevy Chase, Maryland 20815
?
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Clinical Trial Facility
Nashville, Tennessee
?
mi
from
Nashville, TN
Click here to add this to my saved trials